Asterias Biotherapeutics Stock Debt To Equity
Asterias Biotherapeutics fundamentals help investors to digest information that contributes to Asterias Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Asterias Stock. The fundamental analysis module provides a way to measure Asterias Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asterias Biotherapeutics stock.
Asterias |
Asterias Biotherapeutics Company Debt To Equity Analysis
Asterias Biotherapeutics' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Asterias Biotherapeutics Debt To Equity | 0.16 % |
Most of Asterias Biotherapeutics' fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Asterias Biotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Asterias Biotherapeutics has a Debt To Equity of 0.16%. This is 99.7% lower than that of the sector and 99.17% lower than that of the Debt To Equity industry. The debt to equity for all United States stocks is 99.67% higher than that of the company.
Asterias Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Asterias Biotherapeutics' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Asterias Biotherapeutics could also be used in its relative valuation, which is a method of valuing Asterias Biotherapeutics by comparing valuation metrics of similar companies.Asterias Biotherapeutics is currently under evaluation in debt to equity category among its peers.
Asterias Fundamentals
| Return On Equity | -93.17 | |||
| Return On Asset | -0.68 | |||
| Profit Margin | (4.60) % | |||
| Current Valuation | 40.31 M | |||
| Shares Outstanding | 55.66 M | |||
| Shares Owned By Insiders | 40.33 % | |||
| Shares Owned By Institutions | 13.75 % | |||
| Number Of Shares Shorted | 409.74 K | |||
| Price To Earning | (3.41) X | |||
| Price To Book | 2.02 X | |||
| Price To Sales | 67.77 X | |||
| Revenue | 731 K | |||
| Gross Profit | 3.88 M | |||
| EBITDA | (41.26 M) | |||
| Net Income | (20.3 M) | |||
| Cash And Equivalents | 12.59 M | |||
| Cash Per Share | (0.61) X | |||
| Total Debt | 16 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 6.50 X | |||
| Book Value Per Share | 1.16 X | |||
| Cash Flow From Operations | (15.82 M) | |||
| Short Ratio | 2.31 X | |||
| Earnings Per Share | (0.37) X | |||
| Number Of Employees | 31 | |||
| Beta | 3.73 | |||
| Market Capitalization | 52.6 M | |||
| Total Asset | 66.98 M | |||
| Retained Earnings | (59.85 M) | |||
| Working Capital | 19.54 M | |||
| Current Asset | 29.79 M | |||
| Current Liabilities | 10.25 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Asterias Stock
If you are still planning to invest in Asterias Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asterias Biotherapeutics' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |